Recursion jumps after solid Q4 beat

Recursion Pharmaceuticals (RXRX) stock surged after the company significantly beat Street forecasts with its Q4 2025 results.
Blockonomi

Cathie Wood ARK ETF Buys Recursion Pharmaceuticals and CRISPR Therapeutics Shares

Cathie Wood's ARK Invest bought Recursion Pharmaceuticals and CRISPR Therapeutics while selling PagerDuty, Teradyne, and Salesforce on8, 2026.
Visual Studio Magazine

Decision Tree Regression from Scratch Without Pointers or Recursion Using C#

Dr. James McCaffrey presents a complete end-to-end demonstration of decision tree regression from scratch using the C# language. The goal of decision tree regression is to predict a single numeric ...
UC San Diego Today

A New Method to Steer AI Output Uncovers Vulnerabilities and Potential Improvements

A team of researchers has found a way to steer the output of large language models by manipulating specific concepts inside ...